Company: TDBCP
Filing Date: 2025-06-17
Form Type: 424B3
Source: 0001140361-25-022771
Chunk: 2

Company: TORONTO DOMINION BANK
Filing Date: 2025-06-17
Form: 424B3
Chunk 2
---
 Alternatively, we will appoint BofAS or one of its affiliates to act as the calculation agent for the SUNs. When we refer to a “calculation agent” 
 in this product supplement or in any term sheet, we are referring to the applicable calculation agent or joint calculation agents, as the case may be. See “Description of the SUNs—Role of the Calculation Agent.”                       |
| Agents:        | BofAS and one or more of its affiliates and TDS will act as our agents in connection with each offering of the SUNs and will receive an underwriting discount based                                                                       
 on the number of units of the SUNs sold. See “Supplemental Plan of Distribution (Conflicts of Interest)” for additional information. None of the agents is your fiduciary or advisor solely as a result of the making of any offering of  
 the SUNs, and you should not rely upon this product supplement, the applicable term sheet, or the accompanying prospectus as investment advice or a recommendation to purchase the SUNs.                                                  |
| Listing:       | Unless otherwise specified in the applicable term sheet, the SUNs will not be listed on a securities exchange or quotation system.                                                                                                        |

This product supplement relates only to the SUNs and does not relate to any Index or Underlying Fund that comprises the Market Measure described in any applicable term sheet. You should read carefully the entire accompanying prospectus and this product supplement, together with the applicable term sheet, to understand fully the terms of your SUNs, as well as the tax and other considerations important to you in making a decision about whether to invest in the SUNs. In particular, you should review carefully the sections in this product supplement and the accompanying prospectus entitled “Risk Factors,” which highlight a number of risks of an investment in the SUNs, to determine whether an investment in the SUNs is appropriate for you. Additional risk factors may be set forth in the applicable term sheet. If the terms or information described in the applicable term sheet and/or this product supplement are inconsistent with information described in this product supplement and/or in the accompanying prospectus, as applicable, the following hierarchy will govern: first, the applicable term sheet; second, this product supplement; and last, the accompanying prospectus. You should carefully review the applicable term sheet to understand the specific terms of your SUNs. None of us, the agents or our or their respective affiliates is making an offer to sell the SUNs in any jurisdiction where the offer or sale is not permitted. This product supplement